Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kruithof

Showing results (141-150 of 493) with videos related to

Pageof 50
Sort By:
FEBS Letters|March 28, 1988
Determination of intermediates, products and cleavage site in the reaction between plasminogen activator inhibitor type-2 and urokinasesU Kiso, H Kaudewitz, A Henschen, et al.
Clinical Science (London, England : 1979)|November 1, 1990
Short-term infusions of insulin, triacylglycerol and glucose do not cause acute increases in plasminogen activator inhibitor-1 concentrations in manP J Grant, E K Kruithof, C P Felley, et al.
Biochimica Et Biophysica Acta|January 15, 2000
Regulated von Willebrand factor (vWf) secretion is restored by pro-vWf expression in a transfectable endothelial cell lineC Rosnoblet, A S Ribba, C B Wollheim, et al.
British Journal of Cancer|September 1, 1996
Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cellsC Trân-Thang, E Kruithof, H Lahm, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1997
Effects of intermittent pneumatic compression on venous haemodynamics and fibrinolytic activityY Christen, R Wütschert, D Weimer, et al.
Developmental Biology|June 7, 2006
BMP and FGF regulate the differentiation of multipotential pericardial mesoderm into the myocardial or epicardial lineageBoudewijn P T Kruithof, Bram van Wijk, Semir Somi, et al.
Lancet (London, England)|December 16, 2000
Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptomsF Van den Bosch, E Kruithof, M De Vos, et al.
The Journal of Clinical Investigation|December 1, 1982
Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinaseJ D Tissot, P Schneider, J Hauert, et al.
Cancer Gene Therapy|June 7, 2008
Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma modelF Solly, R Fish, B Simard, et al.
Archives of Toxicology|January 9, 2015
Inhibition of TGFβ type I receptor activity facilitates liver regeneration upon acute CCl4 intoxication in miceSofia Karkampouna, Marie-José Goumans, Peter Ten Dijke, et al.
Pageof 50

Showing results (141-150 of 493) with videos related to

Sort By:
Pageof 50
FEBS Letters|March 28, 1988
Determination of intermediates, products and cleavage site in the reaction between plasminogen activator inhibitor type-2 and urokinasesU Kiso, H Kaudewitz, A Henschen, et al.
Clinical Science (London, England : 1979)|November 1, 1990
Short-term infusions of insulin, triacylglycerol and glucose do not cause acute increases in plasminogen activator inhibitor-1 concentrations in manP J Grant, E K Kruithof, C P Felley, et al.
Biochimica Et Biophysica Acta|January 15, 2000
Regulated von Willebrand factor (vWf) secretion is restored by pro-vWf expression in a transfectable endothelial cell lineC Rosnoblet, A S Ribba, C B Wollheim, et al.
British Journal of Cancer|September 1, 1996
Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cellsC Trân-Thang, E Kruithof, H Lahm, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1997
Effects of intermittent pneumatic compression on venous haemodynamics and fibrinolytic activityY Christen, R Wütschert, D Weimer, et al.
Developmental Biology|June 7, 2006
BMP and FGF regulate the differentiation of multipotential pericardial mesoderm into the myocardial or epicardial lineageBoudewijn P T Kruithof, Bram van Wijk, Semir Somi, et al.
Lancet (London, England)|December 16, 2000
Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptomsF Van den Bosch, E Kruithof, M De Vos, et al.
The Journal of Clinical Investigation|December 1, 1982
Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinaseJ D Tissot, P Schneider, J Hauert, et al.
Cancer Gene Therapy|June 7, 2008
Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma modelF Solly, R Fish, B Simard, et al.
Archives of Toxicology|January 9, 2015
Inhibition of TGFβ type I receptor activity facilitates liver regeneration upon acute CCl4 intoxication in miceSofia Karkampouna, Marie-José Goumans, Peter Ten Dijke, et al.
Pageof 50